|
AU2903999A
(en)
*
|
1998-03-12 |
1999-09-27 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
|
|
IL150961A0
(en)
|
2000-02-04 |
2003-02-12 |
Univ Duke |
Human immunodeficiency virus vaccine
|
|
AU2001254567A1
(en)
*
|
2000-05-02 |
2001-11-12 |
Simon Fraser University |
Polypeptides for use as a vaccine and/or treatment for hiv infection
|
|
US20030228320A1
(en)
*
|
2000-08-18 |
2003-12-11 |
Ashdown Martin Leonard |
Retroviral immunotherapy
|
|
AUPS065002A0
(en)
|
2002-02-20 |
2002-03-14 |
Immunaid Pty Ltd |
Strategy for retroviral immunotherapy
|
|
AU2001291050A1
(en)
|
2000-09-15 |
2002-03-26 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Viral chemokine-tumur antigen fusion proteins
|
|
AU2001291049A1
(en)
|
2000-09-15 |
2002-03-26 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer |
Defensin-antigen fusion proteins
|
|
WO2002064154A2
(en)
*
|
2001-02-15 |
2002-08-22 |
The Government Of The United States Of America, Asrepresented By The Secretary Of The Department Of Health And Human Services |
Methods and compositions for inhibiting hiv-coreceptor interactions
|
|
AUPS054702A0
(en)
*
|
2002-02-14 |
2002-03-07 |
Immunaid Pty Ltd |
Cancer therapy
|
|
AU2003298912B2
(en)
*
|
2002-12-03 |
2011-06-02 |
Advanced Bioscience Laboratories, Inc. |
Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods
|
|
WO2004110384A2
(en)
*
|
2003-06-12 |
2004-12-23 |
Vaxgen, Inc. |
Hiv-1 envelope glycoproteins having unusual disulfide structure
|
|
US8076060B2
(en)
*
|
2003-08-04 |
2011-12-13 |
Emil William Chynn |
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
|
|
DE602004030369D1
(de)
*
|
2003-10-24 |
2011-01-13 |
Immunaid Pty Ltd |
Therapieverfahren
|
|
ATE546733T1
(de)
*
|
2004-09-08 |
2012-03-15 |
Immunaid Pty Ltd |
Therapiestrategie zur behandlung von autoimmunkrankheiten und degenerativen erkrankungen
|
|
AU2005284922B2
(en)
*
|
2004-09-14 |
2010-12-23 |
Coimmune, Inc. |
Strain independent amplification of pathogens and vaccines thereto
|
|
CA2623197A1
(en)
*
|
2005-09-22 |
2007-03-29 |
Prosci Incorporated |
Glycosylated polypeptides produced in yeast mutants and methods of use thereof
|
|
WO2009017743A2
(en)
|
2007-07-30 |
2009-02-05 |
Argos Therapeutics, Inc. |
Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
|
|
KR101701198B1
(ko)
|
2008-06-19 |
2017-02-01 |
배리에이션 바이오테크놀로지스 아이엔씨. |
인플루엔자를 치료하기 위한 조성물 및 방법
|
|
PL2435825T3
(pl)
|
2009-05-27 |
2015-12-31 |
Biotempus Ltd |
Sposoby leczenia chorób
|
|
CA2803282C
(en)
|
2009-07-06 |
2018-05-01 |
David E. Anderson |
Methods for preparing vesicles and formulations produced therefrom
|
|
CN102482666B
(zh)
|
2009-07-06 |
2017-02-08 |
变异生物技术公司 |
制备囊泡的方法和由其产生的制剂
|
|
WO2011119920A2
(en)
|
2010-03-25 |
2011-09-29 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
|
CN103096922B
(zh)
|
2010-07-06 |
2019-08-06 |
变异生物技术公司 |
用于治疗流行性感冒的组合物和方法
|
|
BR112013017939B1
(pt)
|
2011-01-13 |
2022-11-16 |
Variation Biotechnologies Inc |
Composição imunogênica liofilizada termoestável, uso e método para preparação da mesma
|
|
SMT201800284T1
(it)
|
2011-06-10 |
2018-07-17 |
Univ Oregon Health & Science |
Glicoproteine cmv e vettori ricombinanti
|
|
EP2568289A3
(en)
|
2011-09-12 |
2013-04-03 |
International AIDS Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
|
EP2802353A4
(en)
|
2012-01-12 |
2015-12-02 |
Variation Biotechnologies Inc |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
|
|
CN104244984B
(zh)
|
2012-01-27 |
2020-03-31 |
变异生物技术公司 |
用于治疗剂的方法和组合物
|
|
ES2631608T3
(es)
|
2012-06-27 |
2017-09-01 |
International Aids Vaccine Initiative |
Variante de la glicoproteína Env del VIH-1
|
|
CN104955847A
(zh)
|
2012-12-04 |
2015-09-30 |
马里兰州大学(巴尔的摩) |
HIV-1 Env结合抗体、融合蛋白及其使用方法
|
|
EP2848937A1
(en)
|
2013-09-05 |
2015-03-18 |
International Aids Vaccine Initiative |
Methods of identifying novel HIV-1 immunogens
|
|
EP2873423B1
(en)
|
2013-10-07 |
2017-05-31 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
|
US9931394B2
(en)
|
2015-03-23 |
2018-04-03 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|